20230522_Contact_Envelope

DENARASE® News

Are you looking for our latest DENARASE® news? Then our newsroom is the right place for you.
 
We offer you up-to-date information on our product portfolio, our exhibitions and on topics and projects that are currently occupying us. 
Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes
Apr 15, 2025

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Cell & Gene Therapy Insights 2025; 11(3), 307–319 · DOI: 10.18609/cgti.2025.035Published: 26 March...
read more
c-LEcta Announces Launch of GMP Grade DENARASE® High Salt
Mar 25, 2025

c-LEcta Announces Launch of GMP Grade DENARASE® High Salt

Leipzig, Germany, 25th March 2025 – c-LEcta, a leading international supplier of enzymes for the...
read more
Switching to DENARASE®: Regulatory considerations for Biopharmaceutical Manufacturing
Feb 13, 2025

Switching to DENARASE®: Regulatory considerations for Biopharmaceutical Manufacturing

c-LEcta GmbH, a leading biotechnology company, has released a new guidance document to support the...
read more
Highly efficient DNA removal in Viral Vector Manufacturing
Sep 11, 2024

Highly efficient DNA removal in Viral Vector Manufacturing

In this presentation we will show you how we used our proprietary engineering platform ENESYZ® for...
read more
Upcoming Webinar: Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes
Jul 30, 2024

Upcoming Webinar: Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes

Tuesday 27th August 202408:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST Live30 webinars are...
read more
c-LEcta launches DENARASE® High Salt for enhanced process flexibility in Viral Vector Manufacturing
Mar 5, 2024

c-LEcta launches DENARASE® High Salt for enhanced process flexibility in Viral Vector Manufacturing

c-LEcta, a leading international supplier of enzymes for the biopharmaceutical industry announces...
read more
How to compare the technical performance of 𝙎𝙚𝙧𝙧𝙖𝙩𝙞𝙖 𝙢𝙖𝙧𝙘𝙚𝙨𝙘𝙚𝙣𝙨 endonucleases such as DENARASE & Benzonase?
Sep 28, 2023

How to compare the technical performance of 𝙎𝙚𝙧𝙧𝙖𝙩𝙞𝙖 𝙢𝙖𝙧𝙘𝙚𝙨𝙘𝙚𝙣𝙨 endonucleases such as DENARASE & Benzonase?

Endonucleases are widely used in the manufacturing of viral vectors for cell and gene therapies....
read more
c-LEcta increases market presence in the USA
Sep 13, 2023

c-LEcta increases market presence in the USA

c-LEcta establishes a US warehouse for R&D-grade DENARASE® portfolio and partners with local...
read more
c-LEcta @ Bioprocessing Summit & BPI Boston
Jun 26, 2023

c-LEcta @ Bioprocessing Summit & BPI Boston

In August and September c-LEcta is presenting their DENARASE® portfolio: DENARASE® for research and...
read more
Accelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes from c-LEcta
May 4, 2023

Accelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes from c-LEcta

During BPI US West in San Diego, our Head of Marketing Raphael Gübeli talked about recent trends...
read more